MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Alcohol Use Disorder in Europe
LA JOLLA, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…